A. Merched et al., CEREBROSPINAL-FLUID APOLIPOPROTEIN-E LEVEL IS INCREASED IN LATE-ONSETALZHEIMERS-DISEASE, Journal of the neurological sciences, 145(1), 1997, pp. 33-39
Worldwide evidence has recently shown that the allele epsilon 4 of apo
lipoprotein E (ApoE) is a genetic risk factor for Alzheimer's disease
(AD) underlining the possible role of apoE in the physiopathology of A
D. To evaluate the usefulness of apoE concentration in pathogenesis of
AD, we measured the cerebrospinal fluid (CSF) levels of apoE. CSF apo
E level was significantly higher in 38 patients with late-onset AD tha
n in 31 control patients and 47 patients suffering from other neurolog
ical and related diseases. Higher levels of CSF apoE were also present
in a subset of patients with meningoencephalitis, motor neuron diseas
e, and low back pain. The increase of CSF-apoE in AD is in agreement w
ith results from studies that find an increase of mRNA apoE in the bra
ins of AD patients. Compared to other works, these results underline t
he importance and the difficulties of the selection of the controls. T
he CSF apoE level seems to be a reflection of neuronal damage and/or a
n inflammatory reaction that may be common to AD and other neurologica
l and related diseases. (C) 1997 Elsevier Science B.V.